Soluble oligomers of amyloid-beta (AβO) transmit neurotoxic signals through the cellular prion protein (PrP C ) in Alzheimer's disease (AD). Secreted stress-inducible phosphoprotein 1 (STIP1), an Hsp70 and Hsp90 cochaperone, inhibits AβO binding to PrP C and protects neurons from AβO-induced cell death.
INTRODUCTION
Neurotoxic assemblies composed of soluble oligomers of the amyloid-beta peptide (AβO), derived from the sequential proteolytic cleavage of the amyloid precursor protein (APP), are thought to be critical for neurotoxicity in Alzheimer's disease (AD) [1, 2] . AβOs interact with numerous neuronal receptors or channel proteins resulting in impairment of synaptic plasticity, oxidative stress, disruption of Ca 2+ homeostasis, inhibition of long-term potentiation (LTP) and neuronal cell death [3] [4] [5] [6] .
The cellular prion protein (PrP C ) is a high affinity AβO receptor that has garnered interest in relation to AβO-induced synaptic dysfunction [6] [7] [8] . PrP C is a highly expressed cell surface glycoprotein which functions as a membrane scaffold for numerous ligands resulting in modulation of cellular signaling events [9] . PrP C -AβO complex formation is coupled to activation of Fyn kinase through mGluR5 resulting in deregulation of NMDA receptors and calcium signaling [10] [11] [12] .
Residues 23-27 and 95-110 of the disordered N-terminal region of PrP C have been proposed to mediate AβO binding [6, 13, 14] . Moreover, impairment of binding to residues 95-110 seems to alleviate AβO neurotoxicity [6, 7] . While PrP C is not essential for all AβO-induced deficits, inhibition of hippocampal LTP, impaired synaptic plasticity, loss of dendritic spines and neuronal cell death seem to be PrP Cdependent [6, 8, 15] . Disruption of AβO binding by antibodies directed against PrP C mitigate AβO induced neurotoxicity, suggesting that modulation of AβO-PrP C interactions may be of therapeutic value in AD [7, [16] [17] [18] . Notably, a ligand of PrP C , stress-inducible phosphoprotein 1 (STIP1), can inhibit AβO toxicity in neurons in a PrP C -dependent manner [19] . Moreover, decreased levels of STIP1 in mammalian neurons or knockdown of STIP1 in C. elegans increases the toxicity of amyloid peptides [19, 20] .
STIP1 is a cellular cochaperone that coordinates Hsp70 and Hsp90 interactions during folding of various cell cycle regulators and signal transduction proteins [21] . Interestingly, Hsp70, Hsp90 and STIP1 all can be secreted to the extracellular space through non-canonical pathways by extracellular vesicles, where they can increase cellular resilience by acting as extracellular chaperones or by signaling via membrane receptors [22] [23] [24] [25] . In particular, STIP1 is secreted by astrocytes into the extracellular space, where it functions as a signaling molecule through PrP C [22, 26] . Complex formation with PrP C induces neuroprotective and neuroproliferative signaling via PKA and ERK pathways, respectively [27, 28] , which is initiated by Ca 2+ influx through the α7 nicotinic acetylcholine receptor (α7nAChR) in hippocampal neurons [29] .
STIP1 is a modular protein composed of three structurally related tetratricopeptide repeat domains (TPR1, TPR2A and TPR2B), as well as two aspartate-proline-rich regions (DP1 and DP2).
Hsp engagement is facilitated through sequential interactions with the TPR domains. Binding of Hsp70
and Hsp90 to the TPR1/TPR2B and TPR2A domains of the cochaperone STI1P, respectively, allows the transfer of clients from Hsp70 to Hsp90 [21, [30] [31] [32] [33] . However, recent work suggests that interaction between STIP1 and Hsp90 is comprised of more extensive interactions with the N-terminal domain and middle domain of Hsp90 [34, 35] . Previous work indicated that amino acids 113-128 within PrP C are critical for STIP1 interaction [19, 26, 36] . Giving that STIP1 could potentially interact with PrP C , Hsp90 and Hsp70 in the extracellular space, and this may modulate AβO toxicity, it is of importance to understand these protein interactions at the molecular level.
Here we provide structural insights into the roles of individual domains of STI1P in interacting with PrP as well as in inhibiting the AβO-PrP binding. In addition, the potential of complex formation between STI1P, PrP, and Hsp90 is explored. Our results reveal multiple domain interactions between STIP1 and PrP are involved in complex formation and that the Hsp-interacting domains, TPR1 and TPR2A, directly inhibit AβO binding to PrP and neuronal toxicity. In addition, we show that Hsp90 is able to influence the interaction of STIP1 with PrP, inhibiting the neuroprotective role of STIP1 against AβO insult.
MATERIALS AND METHODS

Protein expression and purification
pDEST17 expression vectors (Invitrogen) containing genes encoding various mouse STIP1 domains (i.e. full-length STIP1, TPR1 (residues 1 -118), DP1 (residues 119-216), TPR2A (residues 217-352), TPR2B (residues 353-480) and DP2 (residues 481-542)) with an additional N-terminal tobacco etch virus (TEV) cleavable 6xHis tag were transformed into Escherichia coli (E. coli) BL21
(DE3) pLysS strain. E. coli were grown in standard M9 minimal media at 37 o C to an OD 600 of 0.9, at which point over-expression was induced with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG).
Temperature was reduced to 22 o C and cultures were grown overnight.
Proteins were initially purified by Ni 2+ -affinity chromatography using Ni Sepharose 6 Fast Flow beads (GE Healthcare). 6xHis tag was cleaved by incubation with 6xHis tagged TEV overnight at room temperature. Following cleavage, TEV and 6xHis tag were removed by an additional Ni 2+ -affinity chromatography purification [37] . For nuclear magnetic resonance (NMR) spectroscopy, protein was grown in standard M9 minimal medium supplemented with 1 g/L 15 N-labeled ammonium chloride.
Proteins were flash-frozen in liquid nitrogen and stored at -80 o C for no longer than a month. All NMR studies were conducted with freshly prepared protein. For assessing PrP influence on Hsp90 binding to STIP1, polystyrene plates were covered with 10 µg of STIP1 and blocked as described above. After thorough washing, plates were incubated with various concentrations of PrP for 1 hour at room temperature, followed by incubation with 2 µM Hsp90 for 1 hour. After subsequent washing, wells were probed with rabbit anti-Hsp90 (1:1000, Cell
Signaling) in PBS-T and bound Hsp90 was detected as outlined above. 
Surface plasmon resonance (SPR)
All SPR experiments were performed using a Biacore X system equipped with a CM 5 sensor chip (GE Healthcare). The chip was uniformly coated with PrP (23-231) using a standard aminecoupling method to an SPR signal of ~7000 resonance units (RU). Ligands were injected in 10 mM HEPES, 150 mM NaCl, pH 7, over an association period of 7 minutes at a flow rate of 5 µL/min. Offkinetics were measured for an additional 2 minutes following the end of sample injections. The CM5 chip surface was regenerated using a 10 mM hydrochloric acid pulse for 1 minute at a flow rate of 100 µL/min between ligand injections.
Primary neuronal culture
Primary cultures of hippocampal neurons were obtained from E17.5 brains of wild-type (Prnp +/+ ) mice from a C57BL6 background and prepared as previously described [19] . Hippocampi were aseptically dissected in HBSS (Invitrogen) and cells were dissociated in 0.25% trypsin at 37 o C for 20 minutes. Proteolysis was inactivated by re-suspension and dissociation of cells in Minimum
Essential Media (MEM) (Invitrogen) supplemented with 10% Fetal Bovine Serum, penicillin (100 IU), streptomycin (100 µg/mL) and glucose (0.5%). Cultures were maintained on poly-lysine-coated coverslips or plates in Neurobasal Media (Invitrogen) supplemented with 2% B-27 (Invitrogen), penicillin (100 IU), streptomycin (100 µg/mL) and L-glutamine (500 µM). Half of the culture media was replaced every 3-4 days for the duration of the culture.
Cell death viability assay
Hippocampal cultures ( γ-tubulin and amyloid-β were detected by subsequent incubation with secondary Alexa Fluor-488 and Alexa Fluor-633-conjugated antibodies (Invitrogen), respectively, for 1 hour at room temperature.
Immunofluorescence was detected on an LSM510 confocal microscope equipped with a 63x/1.4NA
oil-immersion objective lens. The resultant fluorescence from neurites was integrated using NIH ImageJ software.
RESULTS
Mapping of AβO interface on PrP
Previous studies have revealed that residues 95-110 of PrP C play a pivotal role in mediating the interaction with AβO [6, 13, 16] . To refine the AβO binding-site on PrP in a residue specific basis, we 
Identification of STIP1 binding domains of PrP
We next sought to identify domains of STIP1 that bind PrP and the respective regions of PrP that mediate the interactions. Previous studies have identified the TPR2A domain of STIP1 as the major interaction site for PrP [19, 26, 36] . However, additional regions of STIP1 may be involved in PrP binding due to the modular structure of STIP1 and the structural similarity shared between its TPR domains. Of particular interest were STIP1 domains that specifically bind to PrP (90-231), since they may impair PrP-AβO complex and provide a mechanistic basis for STIP1 neuroprotective properties against AβO insult [19] . We tested binding of STIP1 and its domains using a multi-well protein- binding sites on PrP are either overlapping or in close proximity) ( Figure 2E ).
TPR1 and TPR2A prevent AβO binding to PrP
We have previously demonstrated that the TPR2A domain of STIP1 is able to inhibit AβO binding to PrP, albeit with lower potency than full length STIP1 [19] . Given that TPR1 and TPR2A can both bind to the C-terminal part of PrP (residues 90-231), we investigated whether TPR1 can modulate 
TPR1 and TPR2A inhibit AβO binding and toxicity in neurons
STIP1 is a neuroprotective regulator of AβO toxicity in hippocampal neurons and TPR2A
domain by itself can reproduce this effect [19] . We therefore investigated whether in vitro inhibition of Co-treatment with STIP1, TPR1 or TPR2A rescued neuronal death from AβO induced toxicity ( Figure   4C ). No discernible effect on cell viability was seen in cells co-treated with DP1 and AβO compared to AβO treatment alone.
Mapping of TPR1 and TPR2A interfaces mediating PrP binding
To gain molecular understanding of the STIP1-PrP interactions, NMR spectroscopy was used to map the binding interfaces of PrP on TPR1 and TPR2A on a residue-specific manner. 1 H -15 N HSQC spectra of TPR1 and TPR2A showed comparable amplitude of chemical shift perturbations upon addition of PrP ( Figures 5A and 5C ). Resonances undergoing fast exchange (i.e. chemical shift difference between the free and bound states is small compared to the rate of exchange between these two states) were traced upon titration of PrP and were mapped onto the crystal structures of TPR1 and TPR2A ( Figures 5B and 5D ). Notable chemical shift changes were observed for residues Asp70, Trp71, Gly98, Lys100, His101 and Ala103 of TPR1, which form a contiguous patch on the surface of the C-terminal part of the TPR1 structure ( Figure 5B Figure 6A ). Therefore, we examined the potential for cooperative binding and complex formation for STIP1, PrP and Hsp90.
STIP1 was adsorbed onto polystyrene plates and probed with PrP. Following thorough washing of the complex; plates were incubated with a constant amount of Hsp90 (4 µM) and bound Hsp90 was detected using antibodies directed against Hsp90. Intriguingly, by increasing the concentration of PrP we achieved a saturable increase in Hsp90 binding to the plate ( Figure 6B ). In contrast, no Hsp90 binding was detected to PrP immobilized onto a polystyrene plate in the absence of STIP1 ( Figure 6C ).
These data suggest that PrP binding to STIP1 may induce conformational changes in the complex, which in turn may increase the recruitment of Hsp90.
To investigate the potential relevance for the ternary complex formation of STIP1, Hsp90 and PrP in AβO toxicity, primary mouse hippocampal neurons were incubated in the presence of AβO (1 µM) and sub-optimal concentrations of STIP1. STIP1 caused a dose-dependent decrease of AβO-induced cell death ( Figure 6D ). However, addition of excess recombinant Hsp90 (2 µM) prevented STIP1 neuroprotection against AβO ( Figure 6D ). These results suggest that excess Hsp90 is able to block STIP1 neuroprotective signaling, potentially by sequestering the protein or by interfering with signaling events through PrP at the cellular membrane.
DISCUSSION
AβOs have been demonstrated to trigger synaptic dysfunction through interactions with several neuronal receptors [3] [4] [5] 41] . Numerous studies have identified PrP C as a high affinity receptor for AβOs and implicated the interaction in the transmission of neurotoxic signaling [6, 15, 17] . Disruption of the PrP C -AβO complex has shown therapeutic merit in the reduction of AβO toxicity [7, 19] . We have recently determined that the cellular cochaperone and physiological PrP C ligand STIP1 is able to directly inhibit AβO binding to PrP C and alleviate synaptic loss, depression of long-term potentiation and neuronal cell death [19] . Therefore, understanding how this complex is modulated is of importance.
The studies reported here provide molecular insights regarding the functional modules of STIP1 that directly contribute to its recently described protective role against AβO neurotoxicity and structural details of regions involved in binding to PrP. Our NMR studies revealed significant resonance attenuations in the N-terminal unstructured region of PrP encompassing residues 90-110 upon binding of mature preformed AβOs, suggesting these residues mediate complex formation. These results are consistent with previous observations, which indicated residues centered around 95-110 are essential and sufficient for AβO binding to PrP [6, 7, 13, 14] . Electrostatic potentials of DP1 illustrate a slightly positive groove containing an additional α-helix absent in DP2, which stabilizes secondary structure elements in DP1. Consequently, while both DP1
and DP2 share a common tertiary structure, these distinct structural differences may indicate the inability of DP2 to bind to the N-terminal of PrP.
Even though the function of the DP domains remains uncertain, the length of the linker between TPR1 and TPR2A, which includes the DP1 domain, has recently been proposed to facilitate transfer of Hsp90 from TPR1 to TPR2B during protein client folding [33] . This is the first study to identify a direct ligand of DP1, suggesting the domain may influence STIP1 binding to physiological ligands outside of its cochaperone role in client protein refolding.
We confirmed by SPR the dose-dependent specific interaction between immobilized PrP and AβO. Due to the abnormally long dissociation kinetics, consistent with other studies, we were unable to quantitatively determine a binding constant for the interaction [13, 19, 43] . Thus, the effects of STIP1
and individual domains on AβO were assessed qualitatively based on the absolute magnitude of the response change. STIP1 effectively inhibited AβO binding to PrP, abolishing the interaction at low nanomolar concentrations, as demonstrated previously [19] . TPR2A and TPR1 domains were also Tetratricopeptide repeat motifs are highly degenerate 34 amino acids sequences arranged into helix-loop helix structures forming adjacent anti-parallel helices [46] . The high structural similarity between the TPR1 and TPR2A domains and their similar properties in inhibition of AβO to PrP led us to investigate whether these two regions bind similarly to PrP at the structural level using NMR.
Intriguingly, the binding interfaces of TPR1 and TPR2A with PrP differ significantly. PrP bound TPR1
in a short region encompassing the C-terminus of helix 6 and its respective interconnecting loop region with helix 7. This region is far removed from the traditional TPR binding site involved in proteinprotein interactions.
The TPR2A interface extends diagonally across a hydrophobic cradle-shaped groove on a single face of the TPR2A molecule [30] . Notably, this region overlaps with the Hsp90 binding site of TPR2A, which is formed by electrostatic interactions with highly conserved carboxylate clamp residues of TPR2A and the C-terminal EEVD motif of Hsp90 [30] . Significant chemical shift changes were observed in residues corresponding to the carboxylate clamp, as well as in additional residues occupying the cradle-shaped groove that binds Hsp90.
While Hsp90 plays an important role in assisting and maintaining the proper folding of many non-natively structured proteins, it has been implicated as detrimental in the clearance of hyperphosphorylated tau and Aβ, the pathological species in AD [47] [48] [49] . Along with this, Hsp90 inhibitors have been shown to be effective in facilitating tau clearance and inhibiting Aβ neurotoxicity in mice [50] . In addition, actively secreted Hsp90 also contributes to the regulation of extracellular client proteins [24, 51] . Given that both STIP1 and Hsp90 are secreted, it is plausible that extracellular Hsp90 may influence STIP1 interaction with PrP in the extracellular matrix or on the cell membrane. alone or in the presence of STIP1 (1 µM), TPR1 (2 µM), TPR2A (2 µM) or DP1 (2 µM). Experiments were analyzed by one-way ANOVA, followed by Tukey's post hoc test. ***P < 0.001, (n=3). (0-600 nM) in the presence (red) or absence of HSP90 (2 µM) (black) (n=7). Experiments in the presence or absence of Hsp90 were analyzed by two-way ANOVA, followed by Bonferroni's post hoc test. **P<0.01.
